Companies › Eli Lilly › Diluted EPS

Eli Lilly diluted earnings per share, 2008–2025

Eli Lilly reported diluted earnings per share of $22.95 for the fiscal year ended Dec. 31, 2025, up 96.0% from $11.71 the year before, according to its Form 10-K.

$22.95latest fiscal year (ended Dec. 31, 2025)
+96.0%change from the year before
$22.95highest year shown (2025)
2008: −$1.89 ’08 2009: $3.94 2010: $4.58 ’10 2011: $3.90 2012: $3.66 ’12 2013: $4.32 2014: $2.23 ’14 2015: $2.26 2016: $2.58 ’16 2017: −$0.19 2018: $3.13 ’18 2019: $8.89 2020: $6.79 ’20 2021: $6.12 2022: $6.90 ’22 2023: $5.80 2024: $11.71 ’24 2025: $22.95 ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly diluted earnings per share by fiscal year

Fiscal year endedDiluted EPSChangeFiling
Dec. 31, 2025 $22.95 +96.0% 10-K (2026) ↗
Dec. 31, 2024 $11.71 +101.9% 10-K (2026) ↗
Dec. 31, 2023 $5.80 −15.9% 10-K (2026) ↗
Dec. 31, 2022 $6.90 +12.7% 10-K (2025) ↗
Dec. 31, 2021 $6.12 −9.9% 10-K (2024) ↗
Dec. 31, 2020 $6.79 −23.6% 10-K (2023) ↗
Dec. 31, 2019 $8.89 +184.0% 10-K (2022) ↗
Dec. 31, 2018 $3.13 — 10-K (2021) ↗
Dec. 31, 2017 −$0.19 −107.4% 10-K (2020) ↗
Dec. 31, 2016 $2.58 +14.2% 10-K (2019) ↗
Dec. 31, 2015 $2.26 +1.3% 10-K (2018) ↗
Dec. 31, 2014 $2.23 −48.4% 10-K (2017) ↗
Dec. 31, 2013 $4.32 +18.0% 10-K (2016) ↗
Dec. 31, 2012 $3.66 −6.2% 10-K (2015) ↗
Dec. 31, 2011 $3.90 −14.8% 10-K (2014) ↗
Dec. 31, 2010 $4.58 +16.2% 10-K (2013) ↗
Dec. 31, 2009 $3.94 — 10-K (2012) ↗
Dec. 31, 2008 −$1.89 — 10-K (2011) ↗

Other Eli Lilly financials

RevenueNet incomeR&D expenseOperating cash flowDividends per shareDiluted sharesTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's diluted earnings per share in its latest fiscal year?

A Eli Lilly reported diluted earnings per share of $22.95 for the fiscal year ended Dec. 31, 2025, up 96.0% from $11.71 the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual diluted earnings per share on record here?

A $22.95, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this diluted earnings per share data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Diluted earnings per share as reported. Years reported before the latest stock split are left out rather than adjusted.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Diluted earnings per share as reported. Years reported before the latest stock split are left out rather than adjusted. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.